Aragen has strong manufacturing experience in commercial APIs. Backed by a strong R&D team, we have developed commercially viable processes for several APIs which are regularly supplied to customers globally. We also offer exclusive, long term commercial manufacturing solutions for APIs and advanced intermediates. With rich experience in process development, validation and preparation of drug master files (DMFs), our team fulfils the chemistry manufacturing control (CMC) requirements of customer projects.
Strong expertise in R&D and technology transfer ensures all processes developed at the lab are scaled up to the pilot plant and plant scale. Co-location of R&D labs, pilot plants and commercial manufacturing facilities ensures seamless transfer from feasibility to commercial supply. Our multi-accredited manufacturing facilities are designed to handle a wide range of complex chemistries and operating conditions.
Our manufacturing operations are well integrated with quality control, quality assurance, supply chain management, regulatory and project management, to ensure operational excellence and the consistent production of commercial supplies in a timely and cost-effective manner.
Active Pharmaceutical Ingredients Product Catalogue
| Products | Therapeutic Category | Documents Availability |
|---|---|---|
| Commercially Available | ||
| Dobutamine Hydrochloride | Cardiovascular | CEP/DMF |
| Ezetimibe | Antihyperlipidemic | DMF/KDMF |
| Fingolimod | Multiple Sclerosis | DMF |
| Lamotrigine | Anticonvulsant | CEP/DMF |
| Moxifloxacin Hydrochloride | Antibiotic | CEP/DMF/KDMF |
| Pentosan Polysulfate Sodium | Interstitial Cystitis | USDMF/KDMF/DMF |
| Pralidoxime Chloride | Antidote | DMF |
| Tramadol Hydrochloride | Analgesic | CEP/USDMF/KDMF/JDMF |
| Trimetazidine Dihydrochloride | Cardiovascular | CEP/DMF |
| Products Under Development | ||
| Benserazide | Parkinson’s disease | Validations In Progress |
| Betahistine Di HCl | Anti-Vertigo | Validations In Progress |
| Gatifloxacin | Antibiotic | Lab development in Progress |
| Products | Therapeutic Category |
|---|---|
| Products Under Evaluation | |
| Alizapride HCl | Antiemetic |
| Butamirate citrate | Cough suppressan |
| Roxadustat | Anti-anaemia |
| Vonoprazan Fumarate | Anti-Ulcer |
| Naftifine Hydrochloride | Anti-fungal |
| Tegoprazan | Anti-Ulcer |
| Vibegron | Overactive Bladder |
Intermediates Product Catalogue
| Name of the Intermediates | CAS No |
|---|---|
| Aripiprazole 7-(4-Bromobutoxy)-3,4-Dihydroquinoline-2 (BBQ) | 129722-34-5 |
| Carvedilol 4- (2,3 –Epoxypropoxy) carbazole (CVD4) | 51997-51-4 |
| Lamotrigine Hydrazine carboxidazole -2 – [cyano (2,3 – dichlorophenyl)] methane (LA) | 84689-20-3 |
| Lansoprazole 2-(3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl) methylthio-1H-benzimidazole (LS) | 103577-40-8 |
| Benserazide 2,3,4-Trihydroxybenzaldehyde DL-Serinehydrazide monohydrochloride | 2144-08-3 55819-71-1 |
| Pralidoxime (E)-Picolinaldehdye oxime | 873-69-8 |
Disclaimer: Products covered by valid patents in any country are not offered or supplied to those countries.
The customer should verify the patent position in the concerned country
Drug substance, drug product, analytical and performance chemicals solutions to advance customer programs.
Modern facilities, accredited by all leading regulatory agencies, with world class quality systems and deep manufacturing, analytical and regulatory experience.
Aligning EHS and sustainability initiatives with strategic business value.
